Dr Charles Naltet
- Specialty
- Medical oncologist, lung expert
- Title
- Head of thoracic oncology unit
- Hospital
- Hôpital Saint-Joseph (Paris)
- Latest articles
-
- Durvalumab in Patients With Treatment-Naive Stage IV NSCLC With an ECOG Performance Status of 2 to 3 and High PD-L1 Tumor Expression (IFCT-1802 SAVIMMUNE): A Multicenter Phase 2 Trial. (Sep 18, 2025)
- Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket Trial. (May 1, 2025)
- Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer. (Nov 28, 2024)
- Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience. (Jul 30, 2024)
- Real-life clinical management patterns in extensive-stage small cell lung cancer across France: a multi-method study. (Apr 5, 2024)